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This study was undertaken to investigate possible relationships among plasma adiponectin, 8-iso-prostaglandin F2α (8-iso-PG
F2α: an index of oxidative stress), and membrane ﬂuidity (a reciprocal value of microviscosity) in hypertensive and normotensive
men using an electron spin resonance-method. The order parameter (S) for the spin-label agent (5-nitroxide stearate) in red
blood cell (RBC) membranes was higher in hypertensive men than in normotensive men, indicating that membrane ﬂuidity was
decreased in hypertension. Plasma adiponectin and NO metabolites levels were lower in hypertensive men than in normotensive
men. In contrast, plasma 8-iso-PG F2α levels were increased in hypertensive men compared with normotensive men. Plasma
adiponectin concentration was correlated with plasma NO-metabolites, and inversely correlated with plasma 8-iso-PG F2α.
The order parameter (S) of RBCs was inversely correlated with plasma adiponectin and plasma NO metabolite levels, and
positively correlated with plasma 8-iso-PG F2α, suggesting that the reduced membrane ﬂuidity of RBCs might be associated with
hypoadiponectinemia, endothelial dysfunction, and increased oxidative stress. In a multivariate regression analysis, adiponectin
and 8-iso-PG F2α were signiﬁcant determinants of membrane ﬂuidity of RBCs after adjustment for general risk factors. These
results suggest that adiponectin and oxidative stress might have a close correlation with rheologic behavior and microcirculation
in hypertension.
1.Introduction
It has been shown that dysregulation of adipocytokines
may be accompanied by obesity, diabetes mellitus, dyslipi-
demia, and hypertension, and ﬁnally result in atherosclerotic
vascular diseases [1–4]. Recently, it is strongly suggested
that adiponectin, the most abundant secretory protein of
adipose tissue in human plasma, might actively participate
in the regulation of cardiovascular functions in humans,
because hypoadiponectinemia might be observed in subjects
with hypertension and other cardiovascular diseases [1–4].
It has been demonstrated that plasma adiponectin levels
increased during weight reduction or blockade of the renin-
angiotensin system [5], indicating that adiponectin might be
beneﬁcial for preventing the development of atherosclerotic
changes.
On the other hand, it has also been shown that oxidative
stress might be involved in the pathophysiology of obesity,
hypertension, and atherosclerosis, and might be associated
with increased risk of cardiovascular diseases, vascular
dysfunction, and the metabolic syndrome [6–8]. Evidence
indicates that plasma 8-iso-prostaglandin F2α (8-iso-PG
F2α)maybeareliableindexofoxidativestressinhumans[9–
12]. It was demonstrated that plasma concentration of 8-iso-
PG F2α was signiﬁcantly increased in subjects with essential
hypertension compared with normotensive subjects [9, 10].
It was shown that plasma 8-iso-PG F2α levels were elevated
in patients with coronary artery disease, particularly in those
with hypertension [11, 12]. Moreover, it was shown that
oral administration of vitamin E signiﬁcantly decreased 8-
iso-PG F2α concentrations in overweight/obese individuals,2 Journal of Obesity
suggesting that a decrease in plasma 8-iso-PG F2α has the
potential to reduce the risk of cardiovascular disease in
obesity [13].
Many studies have focused on the cardioprotective
eﬀects attributable to nitric oxide (NO) and have shown
that hypertension and other circulatory disorders may be
associated with insuﬃcient NO production and availability
[14, 15]. Chen et al. [16] demonstrated that adiponectin
may stimulate production of NO in vascular endothelial
cells. It has been shown that plasma adiponectin was
correlated with endothelium-dependent vasodilation of the
brachial artery in humans [2, 17]. In contrast, it was shown
that endothelium-dependent vasodilation was impaired in
subjects with elevated oxidative stress levels [18, 19]. These
ﬁndings suggest that adiponectin and 8-iso-PG F2α might
have a role in the production and bioavailability of NO.
Ithasbeenproposedthatabnormalitiesinphysicochemi-
calpropertiesofthecellmembranesmayunderliethedefects
that are strongly linked to hypertension, stroke, and other
cardiovascular diseases [20–22]. An electron spin resonance
(ESR) and spin-labeling method has been developed to eval-
uate the membrane ﬂuidity and perturbations of the mem-
brane function by external agents [21, 22]. The membrane
ﬂuidity is a reciprocal value of membrane microviscosity and
is an important factor in modulating the cell rheological
behavior[21,22].Wehaveshownthatthemembraneﬂuidity
of red blood cells (RBCs) was signiﬁcantly lower in both
spontaneously hypertensive rats (SHR) and patients with
essential hypertension than in the normotensive controls
[23–26], and proposed that abnormal membrane ﬂuidity of
RBCs might contribute to the pathogenesis of hypertension.
In a study presented recently, we showed that adiponectin
alone[27]or8-iso-PGF2αalone[28]mightbedeterminants
of membrane ﬂuidity of RBCs. In addition, it has been
demonstrated that NO may be involved in the regulation
of cell membrane ﬂuidity [29]. Our previous in vitro study
showed that an NO donor signiﬁcantly improved membrane
ﬂuidity of RBCs in subjects with essential hypertension [30],
indicating that NO could have a beneﬁcial eﬀect on the
rheologic behavior of RBCs and the microcirculation in
hypertension. The present study was performed to assess the
relationships among adiponectin, oxidative stress, and NO,
and their roles in the regulation of membrane ﬂuidity of
RBCs in hypertensive men using the ESR and spin-labeling
method.
2.SubjectsandMethods
2.1. Subjects. A total of 26 men with untreated essential
hypertension were studied and compared with 17 age-
matched normotensive men. The characteristics and labo-
ratory ﬁndings in both groups were shown in Table 1.A l l
subjects had no history of haematologic or hepatic disorders.
All men were nonsmokers. They had similar life styles and
dietary habits, and were instructed to avoid any changes
in dietary habits at least 12 weeks before the study. The
study was approved by a local research committee of Kansai
University of Health Sciences. Written informed consent
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Figure 1: Representative electron spin resonance spectrum of red
blood cells (RBCs) for the fatty acid spin-label agent (5-nitroxide
stearate). S: order parameter, 2T
 
 : outer hyperﬁne splitting, 2T 
⊥:
inner hyperﬁne splitting, Tzz and Txx: hyperﬁne constants, an/a 
n:
isotropic coupling constant, G: gauss. The greater the value of the
order parameter (S) was, the lower the membrane ﬂuidity of RBCs
was.
was obtained from all participants after they were informed
about the nature and objective of the study.
2.2. Measures. Blood sampling was performed by venipunc-
ture after a 30 minutes of bed rest while fasting. The
procedures of RBC preparation and ESR measurements were
shown previously [22–27]. We evaluated the values of outer
and inner hyperﬁne splitting (2T
 
  and 2T
 
⊥ in G, resp.)
in the ESR spectra for the spin label agent (5-nitroxide
stearate, Aldrich Co. Ltd., Milwaukee, Wisconsin, USA) and
calculated the order parameter (S)[ 23–28] (Figure 1). The
greater the value of the order parameter (S) was, the lower
was the membrane ﬂuidity of RBCs [22–27].
Plasma 8-iso-PG F2α levels were determined by using an
enzyme immunoassay (Cayman Chemicals Co., Ann Arbor,
Michigan, USA) [10, 11]. The plasma levels of adiponectin
and NO-metabolites (nitrite and nitrate) were measured
according to the method described previously [1, 27, 28, 31].
2.3.StatisticalAnalysis. Valuesareexpressedasmean ±SEM.
Thediﬀerencesbetweenhypertensiveandnormotensivemen
were analyzed using an unpaired Student’s t-test. Linear
regression analysis was performed to assess the relationships
among membrane ﬂuidity (order parameter; S)o fR B C s ,
plasma adiponectin, plasma 8-iso-PG F2α, and plasma NO-
metabolitelevels.Multivariateregressionanalysiswithmem-
brane ﬂuidity (order parameter; S)o fR B C sa sad e p e n d e n t
variable and plasma adiponectin, plasma 8-iso-PG F2α,a g e ,
body mass index (BMI), fasting plasma glucose, systolic
blood pressure, and plasma total cholesterol as independent
variables was also performed. A P value less than .05 was
accepted as the level of signiﬁcance.
3. Results
3.1. Membrane Fluidity of RBCs in Hypertensive and Nor-
motensive Men. The order parameter (S) for 5-nitroxideJournal of Obesity 3
Table 1: Clinical Characteristics and Laboratory Findings of Hypertensive (HT) and Normotensive (NT) Men.
NT HT
Number of subjects 17 26
Age (y.o.) 65 ±36 3 ±2
Body mass index (kg/m2)2 4 .5 ±0.62 4 .1 ±0.6
Systolic blood pressure (mmHg) 124 ±2 147 ±1∗
Diastolic blood pressure (mmHg) 69 ±28 7 ±1∗
Heart rate (beats/min) 75 ±17 3 ±1
Erythrocyte counts (104 cells/μL 458 ±11 475 ±9
Hemoglobin (g/dL) 14.1 ±0.31 4 .1 ±0.2
Hematocrit (%) 43.1 ±1.04 3 .0 ±0.6
Leucocyte counts (103 cells/μL) 5.5 ±0.35 .4 ±0.2
Platelets (104 cells/μL) 20 ±12 2 ±1
Total cholesterol (mg/dL) 203 ±7 210 ±7
High density lipoprotein cholesterol (mg/dL) 50 ±35 3 ±4
Low density lipoprotein cholesterol (mg/dL) 127 ±6 126 ±6
Triglycerides (mg/dL) 137 ±18 143 ±15
S e r u ms o d i u m( m m o l / L ) 1 4 0 .7 ±0.4 140.1 ±0.3
Serum potassium (mmol/L) 4.1 ±0.14 .0 ±0.1
Serum creatinine (mg/dL) 0.8 ±0.10 .9 ±0.1
Fasting plasma glucose (mg/dL) 120 ±10 119 ±9
Values are means ± SEM. ∗P<. 05 between HT and NT.
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Figure 2: Membrane ﬂuidity of red blood cells (RBCs) in hyper-
tensive and normotensive men. The greater the value of the order
parameter (S) was, the lower the membrane ﬂuidity of RBCs was.
stearate in the ESR spectra of RBC membranes was signiﬁ-
cantly higher in hypertensive men (HT) than in normoten-
sive men (NT) (HT 0.728 ± 0.002, mean ± SEM, n = 26,
NT 0.719 ± 0.002, n = 17, P<. 01) (Figure 2). The ﬁnding
indicated that membrane ﬂuidity of RBCs was decreased in
hypertensive men compared with normotensive men.
3.2. Plasma Adiponectin, Plasma 8-iso-PG F2α,a n dP l a s m a
NO-MetaboliteLevelsinHypertensiveandNormotensiveMen.
Plasma adiponectin concentration was lower in hypertensive
me nthaninno rmot e nsi v eme n(HT7.0±0.3μg/mL, n = 26,
NT 8.3 ± 0.4μg/mL, n = 17, P<. 05). The plasma NO-
metabolites were also lower in hypertensive men than in
normotensive men (HT: 36.3 ± 2.6μmol/L, n = 26, NT:
54.6 ± 5.0μmol/L, n = 17, P<. 01). In contrast, the plasma
8-iso-PG F2α levels were signiﬁcantly higher in hypertensive
men than in normotensive men (HT: 3.33 ± 0.27nmol/L,
n = 26, NT: 2.32 ± 0.18nmol/L, n = 17, P<. 05). In
the overall analysis of hypertensive and normotensive men,
plasma adiponectin concentration was positively correlated
with plasma NO-metabolites (r = 0.334, n = 43, P<. 05)
(Figure3).Itwasalsoclearlyshownthattheplasma8-iso-PG
F2α levels were inversely correlated with plasma adiponectin
(r =− 0.313, n = 43, P<. 05) (Figure 4), and plasma NO-
metabolites (r =− 0.396, n = 43, P<. 01) (Figure 5).
3.3. Relationship among Membrane Fluidity of RBCs, Plasma
Adiponectin, Plasma 8-iso-PG F2α, and NO-Metabolite Levels
inHypertensiveandNormotensiveMen. Theorderparameter
(S)ofRBCswasinverselycorrelatedwithplasmaadiponectin
(r =− 0.405, n = 43, P<. 01) (Figure 6) and plasma
NO metabolite levels (r =− 0.342, n = 43, P<. 05)
(Figure 7), and positively correlated with plasma 8-isoPG
F2α (r = 0.318, n = 43, P<. 05) (Figure 8). These results
might suggest that the reduced membrane ﬂuidity of RBCs
might be associated with hypoadiponectinemia, endothelial
dysfunction, and increased oxidative stress. In a multivariate
regression analysis, both of adiponectin and 8-iso-PG F2α4 Journal of Obesity
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Figure 3: Correlation between plasma adiponectin and plasma
nitric oxide (NO) metabolite levels in hypertensive and normoten-
sive men.
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Figure 4: Inverse correlation between plasma 8-iso-PG F2α and
plasma adiponectin levels in hypertensive and normotensive men.
were signiﬁcant determinants of membrane ﬂuidity of RBCs
after adjustment for general risk factors (Table 2).
4. Discussion
Recent studies have shown that both of adiponectin and
oxidative stress might actively participate in the patho-
physiology of obesity, hypertension, atherosclerosis, and
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Figure 5: Inverse correlation between plasma 8-iso-PG F2α and
plasma nitric oxide (NO) metabolite levels in hypertensive and
normotensive men.
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Figure 6: Inverse correlation between plasma adiponectin levels
and the order parameter (S) of red blood cells (RBCs) in hyper-
tensive and normotensive men.
other cardiovascular and metabolic disease conditions [1–
8]. The present study was performed to evaluate the possible
relationship among adiponectin, oxidative stress, and mem-
brane ﬂuidity of RBCs in hypertensive and normotensive
men using the ESR method. The results showed that
the order parameter (S) of RBC membranes in the ESR
spectra was signiﬁcantly higher in hypertensive men than in
normotensive men, indicating that the membrane ﬂuidity ofJournal of Obesity 5
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Figure 7: Inverse correlation between plasma nitric oxide (NO)
metabolite levels and the order parameter (S) of red blood cells
(RBCs) in hypertensive and normotensive men.
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Figure 8: Correlation between plasma 8-iso-PG F2α levels and the
order parameter (S) of red blood cells (RBCs) in hypertensive and
normotensive men.
RBCs was decreased in hypertension. The ﬁnding might be
consistent with our previous ﬁndings showing that the cell
membranes were stiﬀe ra n dl e s sﬂ u i di nh y p e r t e n s i o n[ 23–
28].
In the present study, plasma adiponectin levels were
signiﬁcantlylowerinhypertensivementhaninnormotensive
men. In contrast, plasma 8-iso-PG F2α levels (an index of
oxidative stress) were signiﬁcantly higher in hypertensive
men than in normotensive men. Furthermore, it was shown
thattheorderparameter(S)ofRBCswasinverselycorrelated
with plasma adiponectin levels, and positively correlated
with plasma 8-iso-PG F2α levels, indicating that the reduced
membrane ﬂuidity of RBCs was associated with hypoad-
iponectinemia and increased oxidative stress. Multivariate
regression analysis also demonstrated that both adiponectin
and plasma 8-iso-PG F2α were independent determinants of
membrane ﬂuidity of RBCs after adjustment for general risk
factors. Because the deformability of RBCs might be highly
dependent on the membrane ﬂuidity [21, 22], the reduction
in membrane ﬂuidity of RBCs could cause a disturbance in
the blood rheologic behavior and the microcirculation in
hypertension.
Le Quan Sang et al. [32] demonstrated that shear
rate, shear stress, and blood viscosity were correlated with
membraneﬂuidityofRBCs.Theyproposedthatinvivoshear
forcesmightparticipateinthecontrolofRBCmembraneﬂu-
idity, and that RBCs might adapt their membrane properties
to blood ﬂow conditions [32]. Saldanha et al. [33] examined
the RBC membrane ﬂuidity of acute myocardial infarction,
and showed that RBC membranes might become more
rigid after myocardial infarction, which could contribute to
the decreased RBC deformability and the increased blood
viscosity in this group of patients. Cazzola et al. [34] also
reported that membrane ﬂuidity of RBCs was decreased
in the obese subjects, and that RBC membranes in obese
subjects had higher susceptibility to peroxidation. They
proposed that a decrease in RBC membrane ﬂuidity could
contribute to a reduction of the rate of blood ﬂow and
the oxygen diﬀusion through the RBC membrane and its
exchange with tissues. It might be possible that alterations
in RBC membrane ﬂuidity with elevated oxidative stress
would be strongly linked to the progression of obesity and
cardiovascular diseases.
Recently, it was demonstrated that adiponectin may
stimulate production of NO in vascular endothelial cells
in vitro [16]. In addition, it has been shown that plasma
adiponectin was correlated with endothelium-dependent
vasodilation of the brachial artery, suggesting that plasma
adiponectin may be a useful marker of endothelial function
in hypertensive subjects [2, 17]. The present study demon-
strated that the plasma levels of the NO metabolites were
signiﬁcantlylowerinhypertensivementhaninnormotensive
men. Furthermore, we showed that the plasma adiponectin
levels were correlated with plasma NO metabolites in the
overall analysis of normotensive and hypertensive men. It
is, therefore, strongly suggested that hypoadiponectinemia
could be associated with the reduced NO production and
endothelial dysfunction. In an in vitro study presented
earlier, we showed that NO signiﬁcantly improved mem-
brane ﬂuidity of RBCs in hypertensive subjects [30]. The
ﬁnding might propose that NO could have a crucial role in
the regulation of membrane ﬂuidity of RBCs, and further
support the hypothesis that adiponectin might be associated
with alterations in membrane ﬂuidity of RBCs, at least
in part, via the NO-dependent mechanism. However, the
inﬂuence of adiponectin on the membrane lipid-protein
interactions [35, 36] cannot be fully excluded.6 Journal of Obesity
Table 2: Multivariate regression analysis for predicting order parameter (S)o fR B C s .
SRC t-value P value
Age −0.025 −0.142 .8878
Body mass index −0.101 −0.616 .5417
Fasting plasma glucose 0.283 2.016 .0515
Systolic blood pressure 0.201 1.390 .1733
Total cholesterol −0.356 −1.939 .0607
Plasma 8-iso-PG F2α 0.332 2.133 .0400
Plasma adiponectin −0.322 −2.195 .0349
R2 = 0.389, n = 43, F = 3.186, P = .0102.
SRC: standard regression coeﬃcient.
The precise mechanisms by which oxidative stress could
aﬀect the membrane functions remain still unclear. Recently,
it was shown that endothelium-dependent vasodilation was
impaired in subjects with elevated oxidative stress levels
[18, 19]. The present study demonstrated that the plasma
8-iso-PG F2α levels were inversely correlated with plasma
NO-metabolite concentration in the overall analysis of
hypertensive and normotensive men. One hypothesis is
that elevated oxidative stress could be associated with the
reduced NO-production and endothelial dysfunction. In the
present study, we demonstrated that the lower membrane
ﬂuidity of RBCs was associated with decreased plasma
NO-metabolite levels. It is suggested that the eﬀects of
oxidative stress on membrane ﬂuidity of RBCs might be
mediated,atleastinpart,byreducingtheNO-bioavailability,
although direct actions of oxidative stress on membrane
structural and functional properties cannot be excluded [37,
38].
Jubelin and Gierman [39] showed that RBCs of rats and
humans are positive for NO synthase, which indicated that
RBCs possess all the cellular machinery to synthesize their
own NO. Chen and Mehta [40] provided direct evidence that
human RBCs possess endothelium-type NO synthase in the
cytosol. It would be possible that the membrane action of
NO could be one of the mechanisms responsible for its ben-
eﬁcial eﬀects in improving the rheological behavior of RBC
membranesandthemicrocirculation.Furtherstudiesshould
be performed to assess more precisely the relationships
among adiponectin, oxidative stress, NO, and membrane
functions, and their contribution to the pathophysiology of
hypertension.
Recently, it was shown that pharmacologic elevation of
serum adiponectin with natural compounds derived from a
medicinal herb, such as astragaloside II and isoastragaloside
I, signiﬁcantly ameliorated hyperglycemia, glucose intoler-
ance,andinsulinresistanceinobesemice[41].Inaddition,it
was demonstrated that direct administration of adiponectin
into the coronary artery reduced the myocardial infarction
size and improved left ventricular function in pigs after
ischemia-reperfusion injury [42]. These ﬁndings support the
idea that adiponectin could be useful for the treatment of
obesity and obesity-related cardiovascular disorders.
5. Conclusion
The results of the present study demonstrated that plasma
adiponectin was signiﬁcantly lower in hypertensive men
than in normotensive men. In addition, plasma adiponectin
concentration was positively correlated with plasma NO
metabolite levels, and inversely correlated with plasma 8-
iso-PG F2α levels. Furthermore, it was shown that the
reduced membrane ﬂuidity of RBCs was correlated with
the decreased plasma adiponectin and NO metabolite levels
and the increased plasma 8-iso-PG F2α levels, suggesting
that abnormalities in RBC membranes in hypertension
might be associated with hypoadiponectinemia, endothelial
dysfunction, and elevated oxidative stress. Although this
is a cross-sectional and correlative study in Japanese men,
the results of the present study could provide a hypothesis
that both adiponectin and oxidative stress might have a
close correlation with the rheologic behavior of RBCs and
the microcirculation, and contribute to the pathophysiology
of hypertension in men. Furthermore, it is possible that
adiponectin couldbeausefulpharmacologictooltoimprove
membrane microviscosity in hypertension via the NO-
dependent mechanisms.
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